Verdict Medical Devices

Foresight announces trial launch for cHL treatment with ctDNA-based MRD test

Foresight Diagnostics has launched the PRECISE-HL trial, which will use the Foresight Clarity LDT to treat patients with advanced-stage cHL. The post Foresight announces trial launch for cHL treatment with ctDNA-based MRD test appeared first on Medical Device Network.

Mar 6, 2025 - 11:11
 0
Foresight announces trial launch for cHL treatment with ctDNA-based MRD test
Foresight Diagnostics has launched the PRECISE-HL trial, which will use the Foresight Clarity LDT to treat patients with advanced-stage cHL.

The post Foresight announces trial launch for cHL treatment with ctDNA-based MRD test appeared first on Medical Device Network.

Read More

Tags:

Previous Article

Orphan drugs: How to avoid costly stock losses in Europe

Next Article

Is Philadelphia the New Hot Spot for New Yorkers?

Related Posts

Cubbie selects Wireless Logic to connect neurodivergence sensory hubs

Cubbie selects Wireless Logic to connect neurodivergenc...

Feb 25, 2025  0

Illumina’s spatial transcriptomics to accelerate breakthroughs in biomedical science

Illumina’s spatial transcriptomics to accelerate breakt...

Feb 25, 2025  0

Siemens Healthineers and Cubresa sign agreement for BrainPET

Siemens Healthineers and Cubresa sign agreement for Bra...

Feb 12, 2025  0